查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1683389

全球智慧型助聽器與語音辨識技術市場 - 2025 至 2033 年

Global Smart Hearing Aids with Speech Recognition Technology Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 215 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球帶有語音辨識技術的智慧助聽器市場規模達到 78.7 億美元，預計到 2033 年將達到 308.3 億美元，在 2025-2033 年預測期內的複合年成長率為 14.6%。

智慧型助聽器是一種先進的設備，可以改善聽力障礙者的生活品質。它們利用無線連接和人工智慧來適應不同的聆聽環境，降低背景噪音，並提高語音清晰度。用戶可以透過將多個數位助聽器連接到智慧型手機來調整設定、傳輸音訊並接收即時語言翻譯。一些型號還具有健康追蹤功能，可以檢測事故並監測脈搏率。智慧型助聽器透過提供個人化的聲音體驗來增強溝通、社交參與和獨立性。

市場動態：

促進因素與約束因素

人工智慧和語音辨識的進步

智慧助聽器中人工智慧和語音辨識技術的融合正在推動市場成長。這些人工智慧輔助設備可以適應不同的聆聽環境，過濾背景噪音，並即時提高語音清晰度。語音命令、自動音量調節和基於機器學習的聲音個性化等功能吸引了用戶，尤其是那些輕度至重度聽力損失的用戶。

人工智慧演算法和深度學習模型的不斷發展有望進一步增強其能力。例如，2025 年 2 月，助聽器創新領域的全球領導者 GN 推出了全球最小的 AI 助聽器 ReSound Vivia 和具有藍牙 LE 音訊和 Auracast 廣播音訊功能的必備系列 ReSound Savi。這些助聽器在嘈雜的環境中提供卓越的音質和舒適度，同時保持尺寸和電池壽命。 GN 的 AI 模型專注於自然聲音處理能力。

高級助聽器價格昂貴

全球智慧助聽器市場面臨挑戰，因為先進設備（尤其是整合人工智慧和語音辨識技術的設備）的成本很高。這使得這些設備不太容易獲得，特別是對於老年人和保險覆蓋範圍有限的發展中地區的人來說。例如，一套助聽器的價格從 1,000 美元到 3,500 美元不等，一對助聽器四年內每天的費用約為 5.57 美元，相當於一杯拿鐵的價格。

此外，維護成本、電池更換和有限的報銷政策進一步阻礙了這些先進助聽器的廣泛應用。

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動態

  • 影響因素
    • 驅動程式
      • 人工智慧和語音辨識的進步
      • 聽力障礙盛行率上升
    • 限制
      • 高級助聽器價格昂貴
      • 嚴格的監管要求
    • 機會
      • 拓展新興市場
    • 影響分析

第5章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 管道分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第 6 章：依產品類型

  • 耳背式 (BTE)
  • 耳內接收器 (RITE)
  • 耳內式 (ITE)
  • 耳道內 (ITC)
  • 其他

第 7 章：依聽力損失類型

  • 神經性聽損失
  • 傳導性聽力損失
  • 混合性聽力損失

第 8 章：按技術

  • 數位的
  • 模擬

第 9 章：依病患組別

  • 成人
  • 兒科

第 10 章：按配銷通路

  • 醫院
  • 門診手術中心 (ASC)
  • 家庭護理設置

第 11 章：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 12 章：競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 併購分析

第 13 章：公司簡介

  • Sonova
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售量
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 主要進展
      • 合併與收購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT 分析
  • Starkey Hearing Technologies
  • GN Hearing A/S
  • Demant
  • Eargo
  • Ambiq
  • WS Audiology A/S
  • Similar data will be provided for each market player.
  • 艾爾戈
    • 管道產品描述
    • 產品關鍵績效指標 (KPI)
    • 主要活動
    • 市場進入時間表
    • 產品滲透率
    • 銷售估計和預測
  • 橄欖聯盟
  • 歌詞聽力
  • 將為每個市場參與者提供類似的資料。

第 14 章：附錄

簡介目錄
Product Code: MD9337

The global smart hearing aids with speech recognition technology market reached US$ 7.87 billion in 2024 and is expected to reach US$ 30.83 billion by 2033, growing at a CAGR of 14.6% during the forecast period 2025-2033.

Smart hearing aids are advanced devices that improve the quality of life for individuals with hearing loss. They use wireless connectivity and artificial intelligence to adapt to different listening environments, reduce background noise, and enhance speech clarity. Users can adjust settings, stream audio, and receive real-time language translation by connecting multiple digital hearing aids to smartphones. Some models also have health-tracking capabilities, detecting accidents and monitoring pulse rate. Smart hearing aids enhance communication, social engagement, and independence by providing personalized sound experiences.

Market Dynamics: Drivers & Restraints

Advancements in Artificial Intelligence and Speech Recognition

The integration of AI and speech recognition technology in smart hearing aids is driving market growth. These AI-powered aids can adapt to different listening environments, filter background noise, and enhance speech clarity in real-time. Features like voice commands, automatic volume adjustments, and machine learning-based sound personalization attract users, particularly those with mild to severe hearing loss.

The continuous development of AI algorithms and deep learning models is expected to further enhance their capabilities. For instance, in February 2025, GN, the global leader in hearing aid innovation, launched the ReSound Vivia, the world's smallest AI-powered hearing aid, and the ReSound Savi, an essentials range featuring Bluetooth LE Audio and Auracast broadcast audio. These hearing aids offer superior sound quality and comfort in noisy environments while maintaining size and battery life. GN's AI model focuses on natural sound processing capabilities.

High Cost of Advanced Hearing Aids

The global smart hearing aids market faces challenges due to the high costs associated with advanced devices, particularly AI-integrated ones with speech recognition technology. This makes these devices less accessible, especially for elderly individuals and those in developing regions with limited insurance coverage and insurance coverage. For instance, The cost of one hearing aid can range from $1,000 to $3,500, with a pair of hearing aids costing about $5.57 per day over four years, equivalent to the cost of a latte.

Additionally, maintenance costs, battery replacements, and limited reimbursement policies further hinder the widespread adoption of these advanced hearing aids.

Segment Analysis

The global smart hearing aids with speech recognition technology market is segmented based on product type, hearing loss type, technology, patient group, distribution channel, and region.

Product Type:

Behind-the-Ear (BTE) segment in the product type is expected to dominate the smart hearing aids with speech recognition technology market

Behind-the-ear (BTE) hearing aids are a key segment in the global smart hearing aids with speech recognition technology market due to their advanced features, comfort, and adaptability. They use advanced speech recognition technology to enhance speech clarity, filter background noise, and improve voice detection in noisy environments. Their wireless connectivity allows seamless integration with smartphones and other smart devices, making them popular among tech-savvy users. The growing prevalence of age-related hearing loss and demand for AI-powered hearing solutions further fuel the market expansion of BTE smart hearing aids.

Additionally, market players are introducing advanced hearing aids. For instance, in October 2024, ELEHEAR launched its latest innovation, ELEHEAR Beyond Hearing Aids, which uses advanced AI technology to enhance sound clarity, provide customizable tinnitus relief, and offer seamless Bluetooth streaming. These hearing aids are priced at an affordable price, making premium hearing aid technology accessible to the masses without compromising quality.

Geographical Analysis

North America is expected to hold a significant position in the smart hearing aids with speech recognition technology market

North America is a significant contributor to the global smart hearing aids with speech recognition technology market, as evidenced by the rapid adoption of advanced healthcare technologies, the increase in the prevalence of hearing impairment, and the geriatric population. For instance, according to WHO, moreover, 5% of the world's population, or 430 million individuals, need rehabilitation for their debilitating hearing loss. It is anticipated that by 2050, approximately 700 million individuals, or one out of every ten, will have debilitating hearing loss. Disabling hearing loss is defined as hearing loss of more than 35 decibels (dB) in the better-hearing ear.

Moreover, strong R&D investments in the region have resulted in ongoing advancements in AI-powered speech recognition and wireless connectivity in hearing aids also significant factors that help the region to grow during the forecast period.

Competitive Landscape

The major global players in the smart hearing aids with speech recognition technology market include Sonova, Starkey Hearing Technologies, GN Hearing A/S, Demant, Eargo, Ambiq, and WS Audiology A/S among others.

Key Developments

  • In February 2025, Beltone introduced its latest innovation, Beltone Envision hearing aids, which offer the world's best technology for noise management and voice clarity. These aids keep users connected to their surroundings and bring important sounds into clear focus, enhancing their listening experience.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Product Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

The global smart hearing aids with speech recognition technology market report delivers a detailed analysis with 69 key tables, more than 70 visually impactful figures, and 215 pages of expert insights, providing a complete view of the market landscape.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Hearing Loss Type
  • 3.3. Snippet by Technology
  • 3.4. Snippet by Patient Group
  • 3.5. Snippet by Distribution Channel
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Advancements in Artificial Intelligence and Speech Recognition
      • 4.1.1.2. Rise in the Prevalence of Hearing Disorders
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost of Advanced Hearing Aids
      • 4.1.2.2. Stringent Regulatory Requirements
    • 4.1.3. Opportunity
      • 4.1.3.1. Expansion into Emerging Markets
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Force Analysis
  • 5.7. Pipeline Analysis
  • 5.8. Supply Chain Analysis
  • 5.9. Patent Analysis
  • 5.10. SWOT Analysis
  • 5.11. Unmet Needs and Gaps
  • 5.12. Recommended Strategies for Market Entry and Expansion
  • 5.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.14. Pricing Analysis and Price Dynamics
  • 5.15. Key Opinion Leaders

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Behind-the-Ear (BTE)*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Receiver-in-the-Ear (RITE)
  • 6.4. In-the-Ear (ITE)
  • 6.5. In-the-Canal (ITC)
  • 6.6. Others

7. By Hearing Loss Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hearing Loss Type
    • 7.1.2. Market Attractiveness Index, By Hearing Loss Type
  • 7.2. Sensorineural Hearing Loss*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Conductive Hearing Loss
  • 7.4. Mixed Hearing Loss

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. Digital*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Analog

9. By Patient Group

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
    • 9.1.2. Market Attractiveness Index, By Patient Group
  • 9.2. Adult*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Pediatric

10. By Distribution Channel

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.1.2. Market Attractiveness Index, By Distribution Channel
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Ambulatory Surgical Centers (ASCs)
  • 10.4. Home Care Settings

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hearing Loss Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.8.1. U.S.
      • 11.2.8.2. Canada
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hearing Loss Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.8.1. Germany
      • 11.3.8.2. U.K.
      • 11.3.8.3. France
      • 11.3.8.4. Spain
      • 11.3.8.5. Italy
      • 11.3.8.6. Rest of Europe
  • 11.4. Latin America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hearing Loss Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.8.1. Mexico
      • 11.4.8.2. Brazil
      • 11.4.8.3. Argentina
      • 11.4.8.4. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hearing Loss Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.8.1. China
      • 11.5.8.2. India
      • 11.5.8.3. Japan
      • 11.5.8.4. South Korea
      • 11.5.8.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hearing Loss Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Patient Group
    • 11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

Key Market Players

  • 13.1. Sonova*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio
      • 13.1.2.1. Product Description
      • 13.1.2.2. Product Key Performance Indicators (KPIs)
      • 13.1.2.3. Historic and Forecasted Product Sales
      • 13.1.2.4. Product Sales Volume
    • 13.1.3. Financial Overview
      • 13.1.3.1. Company Revenue's
      • 13.1.3.2. Geographical Revenue Shares
      • 13.1.3.3. Revenue Forecasts
    • 13.1.4. Key Developments
      • 13.1.4.1. Mergers & Acquisitions
      • 13.1.4.2. Key Product Development Activities
      • 13.1.4.3. Regulatory Approvals etc.
    • 13.1.5. SWOT Analysis
  • 13.2. Starkey Hearing Technologies
  • 13.3. GN Hearing A/S
  • 13.4. Demant
  • 13.5. Eargo
  • 13.6. Ambiq
  • 13.7. WS Audiology A/S
  • Similar data will be provided for each market player.

Emerging Market Players

  • 13.8. Eargo*
    • 13.8.1. Pipeline Products Description
    • 13.8.2. Product Key Performance Indicators (KPIs)
    • 13.8.3. Key Activities
    • 13.8.4. Market Entry Timelines
    • 13.8.5. Product Penetration Rate
    • 13.8.6. Sales Estimation and Projections
  • 13.9. Olive Union
  • 13.10. Lyric Hearing
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us